Pharmaceutical Chemistry

Drug Interactions

Comprehensive guide to drug-drug interactions, pharmacokinetic interactions, and interaction management.

Browse the pages below for detailed information.

retigabine — Kv7.2 Interaction

Drug-target interaction between retigabine and Kv7.2. Synthetic organic pharmacological agent targeting this protein.

retigabine — Kv7.3 Interaction

Drug-target interaction between retigabine and Kv7.3. Synthetic organic pharmacological agent targeting this protein.

retigabine — Kv7.4 Interaction

Drug-target interaction between retigabine and Kv7.4. Synthetic organic pharmacological agent targeting this protein.

retigabine — Kv7.5 Interaction

Drug-target interaction between retigabine and Kv7.5. Synthetic organic pharmacological agent targeting this protein.

ribavirin — inosine monophosphate dehydrogenase 1 Interaction

Drug-target interaction between ribavirin and inosine monophosphate dehydrogenase 1. Synthetic organic pharmacological agent targeting this protein.

ribavirin — inosine monophosphate dehydrogenase 2 Interaction

Drug-target interaction between ribavirin and inosine monophosphate dehydrogenase 2. Synthetic organic pharmacological agent targeting this protein.

ribociclib — cyclin dependent kinase 4 Interaction

Drug-target interaction between ribociclib and cyclin dependent kinase 4. Synthetic organic pharmacological agent targeting this protein.

rimegepant — CGRP receptor Interaction

Drug-target interaction between rimegepant and CGRP receptor. Synthetic organic pharmacological agent targeting this protein.

ripasudil — Rho associated coiled-coil containing protein kinase 1 Interaction

Drug-target interaction between ripasudil and Rho associated coiled-coil containing protein kinase 1. Synthetic organic pharmacological agent targeting this protein.

ripasudil — Rho associated coiled-coil containing protein kinase 2 Interaction

Drug-target interaction between ripasudil and Rho associated coiled-coil containing protein kinase 2. Synthetic organic pharmacological agent targeting this protein.

risedronate — farnesyl diphosphate synthase Interaction

Drug-target interaction between risedronate and farnesyl diphosphate synthase. Synthetic organic pharmacological agent targeting this protein.

risperidone — 5-HT1B receptor Interaction

Drug-target interaction between risperidone and 5-HT1B receptor. Synthetic organic pharmacological agent targeting this protein.

risperidone — 5-HT1D receptor Interaction

Drug-target interaction between risperidone and 5-HT1D receptor. Synthetic organic pharmacological agent targeting this protein.

risperidone — 5-HT2A receptor Interaction

Drug-target interaction between risperidone and 5-HT2A receptor. Synthetic organic pharmacological agent targeting this protein.

risperidone — D2 receptor Interaction

Drug-target interaction between risperidone and D2 receptor. Synthetic organic pharmacological agent targeting this protein.

ritlecitinib — Janus kinase 3 Interaction

Drug-target interaction between ritlecitinib and Janus kinase 3. Synthetic organic pharmacological agent targeting this protein.

rituximab — CD20 (membrane-spanning 4-domains, subfamily A, member 1) Interaction

Drug-target interaction between rituximab and CD20 (membrane-spanning 4-domains, subfamily A, member 1). Antibody pharmacological agent targeting this protein.

rivaroxaban — coagulation factor X Interaction

Drug-target interaction between rivaroxaban and coagulation factor X. Synthetic organic pharmacological agent targeting this protein.

rivastigmine — acetylcholinesterase (Yt blood group) Interaction

Drug-target interaction between rivastigmine and acetylcholinesterase (Yt blood group). Synthetic organic pharmacological agent targeting this protein.

rivastigmine — butyrylcholinesterase Interaction

Drug-target interaction between rivastigmine and butyrylcholinesterase. Synthetic organic pharmacological agent targeting this protein.

rizatriptan — 5-HT1B receptor Interaction

Drug-target interaction between rizatriptan and 5-HT1B receptor. Synthetic organic pharmacological agent targeting this protein.

rizatriptan — 5-HT1D receptor Interaction

Drug-target interaction between rizatriptan and 5-HT1D receptor. Synthetic organic pharmacological agent targeting this protein.

rofecoxib — COX-2 Interaction

Drug-target interaction between rofecoxib and COX-2. Synthetic organic pharmacological agent targeting this protein.

roflumilast — phosphodiesterase 4B Interaction

Drug-target interaction between roflumilast and phosphodiesterase 4B. Synthetic organic pharmacological agent targeting this protein.

romidepsin — histone deacetylase 1 Interaction

Drug-target interaction between romidepsin and histone deacetylase 1. Synthetic organic pharmacological agent targeting this protein.

romiplostim — Thrombopoietin receptor Interaction

Drug-target interaction between romiplostim and Thrombopoietin receptor. Peptide pharmacological agent targeting this protein.

ropinirole — D2 receptor Interaction

Drug-target interaction between ropinirole and D2 receptor. Synthetic organic pharmacological agent targeting this protein.

ropinirole — D3 receptor Interaction

Drug-target interaction between ropinirole and D3 receptor. Synthetic organic pharmacological agent targeting this protein.

rosiglitazone — Peroxisome proliferator-activated receptor-γ Interaction

Drug-target interaction between rosiglitazone and Peroxisome proliferator-activated receptor-γ. Synthetic organic pharmacological agent targeting this protein.

rosuvastatin — hydroxymethylglutaryl-CoA reductase Interaction

Drug-target interaction between rosuvastatin and hydroxymethylglutaryl-CoA reductase. Synthetic organic pharmacological agent targeting this protein.

rotigotine — D2 receptor Interaction

Drug-target interaction between rotigotine and D2 receptor. Synthetic organic pharmacological agent targeting this protein.

rozanolixizumab — Fc fragment of IgG receptor and transporter Interaction

Drug-target interaction between rozanolixizumab and Fc fragment of IgG receptor and transporter. Antibody pharmacological agent targeting this protein.

rucaparib — poly(ADP-ribose) polymerase 1 Interaction

Drug-target interaction between rucaparib and poly(ADP-ribose) polymerase 1. Synthetic organic pharmacological agent targeting this protein.

rupatadine — H1 receptor Interaction

Drug-target interaction between rupatadine and H1 receptor. Synthetic organic pharmacological agent targeting this protein.

ruxolitinib — Janus kinase 1 Interaction

Drug-target interaction between ruxolitinib and Janus kinase 1. Synthetic organic pharmacological agent targeting this protein.

ruxolitinib — Janus kinase 2 Interaction

Drug-target interaction between ruxolitinib and Janus kinase 2. Synthetic organic pharmacological agent targeting this protein.

sacituzumab govitecan — tumor associated calcium signal transducer 2 Interaction

Drug-target interaction between sacituzumab govitecan and tumor associated calcium signal transducer 2. Antibody pharmacological agent targeting this protein.

safinamide — Monoamine oxidase B Interaction

Drug-target interaction between safinamide and Monoamine oxidase B. Synthetic organic pharmacological agent targeting this protein.

salbutamol — β2-adrenoceptor Interaction

Drug-target interaction between salbutamol and β2-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.

salmeterol — β2-adrenoceptor Interaction

Drug-target interaction between salmeterol and β2-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.

sapropterin — L-Phenylalanine hydroxylase Interaction

Drug-target interaction between sapropterin and L-Phenylalanine hydroxylase. Metabolite pharmacological agent targeting this protein.

sarilumab — Interleukin-6 receptor, α subunit Interaction

Drug-target interaction between sarilumab and Interleukin-6 receptor, α subunit. Antibody pharmacological agent targeting this protein.

satralizumab — Interleukin-6 receptor Interaction

Drug-target interaction between satralizumab and Interleukin-6 receptor. Antibody pharmacological agent targeting this protein.

saxagliptin — dipeptidyl peptidase 4 Interaction

Drug-target interaction between saxagliptin and dipeptidyl peptidase 4. Synthetic organic pharmacological agent targeting this protein.

scopolamine — M1 receptor Interaction

Drug-target interaction between scopolamine and M1 receptor. Natural product pharmacological agent targeting this protein.

secretin — secretin receptor Interaction

Drug-target interaction between secretin and secretin receptor. Peptide pharmacological agent targeting this protein.

seladelpar — Peroxisome proliferator-activated receptor-β/δ Interaction

Drug-target interaction between seladelpar and Peroxisome proliferator-activated receptor-β/δ. Synthetic organic pharmacological agent targeting this protein.

selegiline — Monoamine oxidase B Interaction

Drug-target interaction between selegiline and Monoamine oxidase B. Synthetic organic pharmacological agent targeting this protein.

selumetinib — mitogen-activated protein kinase kinase 1 Interaction

Drug-target interaction between selumetinib and mitogen-activated protein kinase kinase 1. Synthetic organic pharmacological agent targeting this protein.

semaglutide — GLP-1 receptor Interaction

Drug-target interaction between semaglutide and GLP-1 receptor. Peptide pharmacological agent targeting this protein.

sermorelin — GHRH receptor Interaction

Drug-target interaction between sermorelin and GHRH receptor. Peptide pharmacological agent targeting this protein.

serplulimab — programmed cell death 1 (CD279) Interaction

Drug-target interaction between serplulimab and programmed cell death 1 (CD279). Antibody pharmacological agent targeting this protein.

sertindole — 5-HT2A receptor Interaction

Drug-target interaction between sertindole and 5-HT2A receptor. Synthetic organic pharmacological agent targeting this protein.

sertindole — 5-HT2C receptor Interaction

Drug-target interaction between sertindole and 5-HT2C receptor. Synthetic organic pharmacological agent targeting this protein.

sertindole — D2 receptor Interaction

Drug-target interaction between sertindole and D2 receptor. Synthetic organic pharmacological agent targeting this protein.

sertindole — D3 receptor Interaction

Drug-target interaction between sertindole and D3 receptor. Synthetic organic pharmacological agent targeting this protein.

sertindole — D4 receptor Interaction

Drug-target interaction between sertindole and D4 receptor. Synthetic organic pharmacological agent targeting this protein.

sertraline — SERT Interaction

Drug-target interaction between sertraline and SERT. Synthetic organic pharmacological agent targeting this protein.

sibutramine — DAT Interaction

Drug-target interaction between sibutramine and DAT. Synthetic organic pharmacological agent targeting this protein.

sibutramine — NET Interaction

Drug-target interaction between sibutramine and NET. Synthetic organic pharmacological agent targeting this protein.